About 100,000 US Covid-19 deaths could be attributed to remdesivir-induced kidney failure – zoohousenews.com

(Natural News) In the past three years, about 100,000 Covid-19 deaths in America have been attributed to remdesivir-induced kidney failure. This estimate was extrapolated from a Massachusetts study conducted by John Beaudoin, which looked at causes of death on individual death certificates before and during the Covid-19 scandal.

Beaudoin filed a Freedom of Information Act request and obtained all death certificates in Massachusetts from 2015 through 2022. After analyzing all cause-of-death data, Beaudoin determined that as of January 1, 2021, there have been 1,840 EXCESS deaths from acute Kidney failure gave until November 30, 2022. He believes these excessive cases of acute kidney failure are the result of a mandatory hospital protocol beginning with the highly toxic remdesivir. His analysis doesn’t even include the risk of cardiac events caused by remdesivir, which is a safety signal recognized by the European Spontaneous Adverse Event Reporting System.

John Beaudoin calls for a criminal investigation.

Remdesivir leads to organ damage, Covid-19 deaths

In May 2020, the US Food and Drug Administration (FDA) approved American hospitals to use an unsuccessful Ebola drug called remdesivir (brand name Veklury). The drug proved to be the least effective and the deadliest in a large study in 2019; However, the FDA granted remdesivir full approval by October 2020. In the study, remdesivir had the highest mortality rate at more than 50%.

In addition, a large study of US veterans found that treatment with remdesivir “was not associated with improved survival, but with longer hospital stays.” Although the drug can cause high rates of kidney failure, it eventually received full approval for pediatric Covid-19 cases and remains the primary treatment for Covid-19 diagnoses in hospitals to this day.

According to studies by the World Health Organization (WHO), remdesivir increases the risk of kidney failure by 20 times and the risk of death by four percent. The WHO advised against the use of remdesivir for Covid-19 back in November 2020, yet American hospitals continue to pump this toxin into patients. Unfortunately, the WHO would eventually recommend remdesivir again in mild or moderate Covid patients who are at high risk of hospitalization.

When patients are isolated from their family members and caregiver advocates, when they are unnecessarily sedated and ventilated, the negative effects of remdesivir amplify. No matter how deadly this protocol is, it is the protocol that has given hospitals their payouts during the Covid-19 emergency; It’s the protocol that paved the way for emergency use of the mRNA vaccine platform. Sadistically, hospital liability protections remain in place, covering their proven harmful protocols and their harmful vaccination programs.

Remdesivir was marketed by the NIAID due to clinical fraud

During the Covid-19 emergency, hospitals have been granted immunity under the PREP Act. Hospitals were also given financial incentives to list Covid-19 as the cause of death on death certificates. The underlying factors and iatrogenic errors that led to these deaths have been ignored and continue to be ignored to this day.

dr Anthony Fauci and the National Institute of Allergy and Infectious Diseases (NIAID) have reused remdesivir after it failed to treat Ebola. The NIAID also manipulated the primary and secondary objectives of remdesivir trials for Covid-19 to obfuscate the results and falsely promote it as an antiviral drug for Covid-19.

Originally, the primary objective of the study was “to assess the clinical efficacy of various investigational therapeutics compared to the control arm in adults hospitalized with COVID-19.” This was changed during the study to calculate “time to recovery by day 29.” The secondary objectives of the study were originally “to assess the clinical efficacy of various investigational therapeutics compared to the control arm, assessed by clinical severity, hospitalization and mortality, and to assess the safety of various investigational therapeutics compared to the control arm,” but were later changed this to “Assess treatment-related improvements on the 8-point ordinal scale at day 15”. In other words, safety and effectiveness have never been proven, but the drug was pushed into the general public by the NIAID anyway.

In 2016, a Johns Hopkins research team found that medical errors are the third leading cause of death, with 250,000 deaths per year in the United States. The team warned that the way the CDC collected national health statistics could NOT separately classify medical errors on the person’s death certificate. The researchers advocate updating the official criteria for grading deaths on death certificates. These updates are urgently needed as renal failure caused by remdesivir appears to be a serious medical malpractice problem across the medical system. In any case, this increase in excess deaths from acute renal failure needs to be investigated.

As remdesivir use continues without apologies, much of the ongoing deaths from Covid-19 can best be described as premeditated homicide, given that the NIAID rigged clinical trials and knew full well in 2019 that remdesivir was a dangerous poison .

Sources include:

Expose-News.com

Pubmed.gov

NEJM.org

NEJM.org [PDF Table S9]

JAMANetwork.com

BMJ.com

WHO.int

ClinicalTrials.gov

HopkinsMedicine.org